Taylor & Francis news

Taylor & Francis Acquires American Society for Microbiology Journal

Photo of research scientist

The American Society for Microbiology (ASM) and Taylor & Francis are pleased to announce today Taylor & Francis’ acquisition of the Molecular and Cellular Biology (MCB) journal from ASM. ASM is one of the oldest and largest single life science membership societies in the world.

The editorial and financial transactions were completed at the end of November.

Molecular and Cellular Biology is a monthly, peer-reviewed, scientific journal established by ASM in 1981. MCB’s scope is rigorous, and includes mechanistic studies that provide significant advances in the areas of gene expression and genome organization, cellular morphology and function, molecular metabolism, cellular trafficking and signal transduction. The journal also focuses on studies that investigate molecular, cellular and systemic host responses to pathogenic agents in chronic diseases and conditions.

MCB grew by 40 percent from 2017 to 2021, increasing from 4.6 million total full-text views to 6.4 million full-text views annually.

The title will be added to Taylor & Francis’ life sciences and medical portfolio, which includes more than 250 journals in Biomedical and Life Sciences and 46 journals in Cell and Molecular Biology, with journals such as Autophagy, Cell Cycle, RNA Biology, Epigenetics, Virulence, and Critical Reviews in Biochemistry and Molecular Biology.

“We’re delighted to welcome Molecular and Cellular Biology to Taylor & Francis,” said Leon Heward Mills, Managing Director, Researcher Services, Taylor & Francis. “While our life sciences and medical portfolio is extensive, the introduction of such a high-quality and well-recognized journal will broaden an area of significant interest to our expert communities here in the United States and worldwide.”

Stefano Bertuzzi, CEO, the American Society for Microbiology, said: “At ASM we are proud of the research that has been published in MCB over the last decades and appreciate all the hard work from the dedicated editors and staff that helped MCB succeed and made it a journal that shaped the field of molecular and cellular biology.”

“At a personal level, it has been one of my must-read journals since I was a graduate student. I am grateful that MCB will continue with renewed energy engaging the community of cellular and molecular biologists in its new home at Taylor & Francis,” Bertuzzi added.

ASM and Taylor & Francis are committed to making this a seamless transition for authors. Taylor & Francis will start accepting author submissions on Dec. 5, 2022, following transition from ASM on Dec. 1, 2022.